2016-07-29 14:57:13 UTC

New CME On-Demand Offering for Patient Care Providers

Aug. 1, 2016

This unique educational program benefits GIs who manage patients with HCV and IBD.

AGA, PRIME Education, Inc. (PRIME) and the Academy of Managed Care Pharmacy (AMCP), are pleased to announce an on-demand, online initiative offering 1.0 CME AMA PRA Category 1 Credit™.

This unique educational program benefits GIs who manage patients with HCV and IBD, based upon the paradigm shifts in treatment and available therapies, as well as issues of cost and health outcomes in these two severe chronic diseases.

This collaborative initiative among the AGA, AMCP and PRIME resulted from research and data analytics of previous PRIME quality improvement research initiatives in HCV and IBD that demonstrate suboptimal processes among GI specialists for managing the resources required to meet managed care treatment review processes.

Moreover, many physicians lack awareness of strategies for collaborating with health plans and specialty pharmacies to ensure that patients are aware of and take full advantage of existing disease management and medication therapy management programs to maximize treatment adherence, lower costs and optimize health outcomes. 

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.